Lysophosphatidic Acid Detection via C8 Solid-Phase Extraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating and detecting lysophosphatidic acids (LPAs) are inefficient due to time-consuming two-dimensional thin layer chromatography, low recovery rates, and inaccuracies caused by interference from other lipids and ionization issues in mass spectrometry, which hinder precise quantification of LPA species in plasma samples.
Innovation Solution
A method involving liquid-liquid extraction followed by solid-phase extraction using a C8 stationary phase, combined with reversed-phase HPLC and a fluorometric assay using a compound like 4-(4-(dihexadecylamino)styryl)-N-methylpyridinium iodide (DiA) for detecting LPAs, allowing for accurate separation and quantification of individual LPA species.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If two-dimensional thin layer chromatography is used to separate LPA from other lipids, then separation is achieved, but the process becomes time consuming and labor intensive
Solution Approach 1:
The patent extracts and isolates LPA from complex lipid mixtures using liquid-liquid extraction followed by solid-phase extraction with C8 stationary phase. This extraction approach removes interfering lipids systematically, achieving clean separation without requiring time-consuming two-dimensional TLC procedures.
Solution Approach 2:
The patent replaces the mechanical manual process of two-dimensional thin layer chromatography with automated liquid-liquid extraction and solid-phase extraction systems. This substitution eliminates manual spotting, developing, and scoring operations, significantly reducing processing time while maintaining separation reliability.
2Measurement precision
If gas chromatography is used to quantify total LPA plasma levels, then quantification is achieved, but the method requires time-consuming two-dimensional TLC separation
Solution Approach 1:
The patent performs preliminary extraction and purification of LPA from plasma using liquid-liquid extraction and solid-phase extraction before quantification. This preliminary action removes interfering substances in advance, allowing direct quantification without requiring subsequent two-dimensional TLC separation steps.
Solution Approach 2:
The patent introduces C8 solid-phase extraction cartridges as an intermediary medium between plasma samples and quantification detection. This intermediary system facilitates selective retention and elution of LPA, enabling clean quantification without manual TLC separation procedures.
3Measurement precision
If capillary electrophoresis is used to quantify individual LPAs, then individual species can be detected, but two-dimensional TLC is required for separation which is labor intensive
Solution Approach 1:
The patent segments the complex lipid mixture separation process into distinct stages: liquid-liquid extraction for bulk separation, solid-phase extraction for selective LPA isolation, and capillary electrophoresis for individual species resolution. This segmentation eliminates the need for manual two-dimensional TLC while maintaining individual species detection capability.
Solution Approach 2:
The patent replaces manual two-dimensional TLC operations with automated liquid-liquid extraction and solid-phase extraction systems, followed by capillary electrophoresis. This mechanical substitution eliminates manual spotting, chamber preparation, and score reading, significantly reducing operational complexity and labor requirements.
4Loss of time
If HPLC with evaporative light-scattering detection is used, then LPA separation is achieved without two-dimensional TLC, but LPA recovery is relatively low
Solution Approach 1:
The patent optimizes extraction parameters including pH adjustment to acidic conditions (pH 2-3) during solid-phase extraction, which enhances LPA binding to C8 cartridges. This parameter change improves recovery efficiency while maintaining the advantage of avoiding two-dimensional TLC and reducing processing time.
Solution Approach 2:
The patent performs preliminary acidification and extraction steps before HPLC analysis to maximize LPA recovery. By preparing samples with optimized pH and complete extraction beforehand, the method achieves high recovery rates without requiring time-consuming separation procedures during analysis.
5Measurement precision
If LC-MS/MS is used to quantify LPAs, then accurate quantification is achieved, but interference from unknown compounds and other lipids reduces accuracy
Solution Approach 1:
The patent systematically extracts and removes interfering lipids through liquid-liquid extraction and solid-phase extraction with C8 cartridges before LC-MS/MS analysis. This extraction approach eliminates unknown compounds and other lipid interferents, allowing accurate quantification of LPA species without spectral interference.
Solution Approach 2:
The patent uses C8 solid-phase extraction cartridges as an intermediary purification step between plasma samples and LC-MS/MS detection. This intermediary system selectively retains LPA while allowing interfering substances to be washed away, ensuring clean quantification and eliminating false signals from other lipids.
6Measurement precision
If negative ion mode is used in mass spectrometry for LPA detection, then ionization is improved, but technical challenge increases compared to positive ion mode
Solution Approach 1:
The patent performs preliminary extraction and purification steps that simplify subsequent mass spectrometry analysis. By removing interfering substances before analysis, the method reduces the operational complexity of negative ion mode MS, making it more manageable while maintaining improved ionization efficiency for LPA detection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables efficient and accurate isolation and detection of LPAs, reducing interference and improving recovery rates, providing a more reliable and cost-effective method for quantifying LPA species in plasma samples compared to existing techniques.
Implementation Method 1
solid-phase extraction using a C8 stationary phase
Implementation Method 2
fluorometric assay using a compound like 4-(4-(dihexadecylamino)styryl)-N-methylpyridinium iodide (DiA) for detecting LPAs
Data Source
AI summary
Embodiments of methods and compounds for isolating and detecting lysophosphatidic acids (LPAs) are disclosed. Kits for performing the methods also are disclosed. LPAs are isolated from biological samples by liquid-liquid extraction followed by solid phase extraction. LPA species may be separated by HPLC, and the separated species may be identified and quantified. Also disclosed are embodiments of compounds capable of universally detecting a plurality of LPA species with substantially equivalent sensitivity. Embodiments of the disclosed compounds are useful for determination of total LPA concentration in a sample comprising a plurality of LPA species without separation of individual LPA species.